![Michael Dougherty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Dougherty
Directeur/Membre du Conseil chez
Altherx, Inc.
Profil
Michael R.
Dougherty is currently Director at AltheRx, Inc. since 2013.
Former positions include President & Chief Executive Officer at Genaera Corp.
from 1998 to 2000; President, Chief Executive Officer & Director at Adolor Corp.
from 2006 to 2011; Chief Executive Officer & Director at Kalidex Pharmaceuticals, Inc. in 2012; Executive Chairman at Jazz Pharmaceuticals Therapeutics, Inc. from 2015 to 2016; Independent Director at Idera Pharmaceuticals, Inc.; Independent Director at Shire ViroPharma, Inc. from 2004 to 2014; Independent Director at Immedica Pharma US, Inc. from 2017 to 2022; Director at Cempra Pharmaceuticals, Inc.; Independent Director at Cempra, Inc. from 2013 to 2017; Independent Director at Trevena, Inc. from 2013 to 2023; Independent Director at Foundation Medicine, Inc. from 2016 to 2018; Independent Non-Executive Director at Aviragen Therapeutics, Inc. from 2013 to 2018; Independent Director at Aceragen, Inc. from 2022 to 2023; Director at ViralClear Pharmaceuticals, Inc.; Chief Financial Officer & Senior Vice President at Centocor, Inc. from 1983 to 1993; and President & Chief Operating Officer at Genomics Collaborative, Inc. from 2000 to 2002.
Education includes an undergraduate degree from Villanova University conferred in 1980.
Postes actifs de Michael Dougherty
| Sociétés | Poste | Début |
|---|---|---|
Altherx, Inc.
 Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Directeur/Membre du Conseil | 30/05/2013 |
Anciens postes connus de Michael Dougherty
| Sociétés | Poste | Fin |
|---|---|---|
| TREVENA, INC. | Directeur/Membre du Conseil | 14/09/2023 |
| ACERAGEN, INC. | Président | 01/09/2022 |
| MARINUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 13/11/2022 |
| FOUNDATION MEDICINE INC | Directeur/Membre du Conseil | 31/07/2018 |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Directeur/Membre du Conseil | 01/02/2018 |
Formation de Michael Dougherty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration | Health Technology |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Health Technology |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Kalidex Pharmaceuticals, Inc.
 Kalidex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops antibiotics for the treatment of serious infections | Health Technology |
Genomics Collaborative, Inc.
 Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Provides clinical samples and the application of human genetics to target validation for drug discovery | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Health Technology |
Altherx, Inc.
Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Commercial Services |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
